Related Experiment Video
Updated: Apr 24, 2026

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time
Felix Jost1, Clemens Giegerich2, Christoph Grebner3
1Translational Medicine Unit, Quantitative Pharmacology, Research Pharmacometrics, Sanofi R&D, Frankfurt, Germany.
Predicting pharmacokinetic (PK) profiles from molecular structures is now viable. Physics-informed neural networks (CMT-PINN) and decision trees (PURE-ML) show the highest accuracy for drug discovery, accelerating timelines.
Area of Science:
- Computational chemistry
- Pharmacokinetics
- Drug discovery
Background:
- Accurate prediction of pharmacokinetic (PK) profiles from molecular structures is crucial for efficient drug discovery.
- Existing methods often require extensive experimental data, delaying the process.
Purpose of the Study:
- To systematically compare five distinct computational frameworks for predicting rat plasma concentration-time profiles directly from molecular structures.
- To evaluate the performance of machine learning (ML) and physics-informed neural networks (PINNs) in PK prediction.
Main Methods:
- Five methodologies were evaluated: NCA-ML, PBPK-ML, CMT-ML, CMT-PINN, and PURE-ML.
- Models were trained and validated on a consistent dataset using a standardized evaluation framework.
- Performance was assessed using R²-log, Spearman correlation, and percentage of predictions within twofold error.
Main Results:
- The CMT-PINN approach demonstrated the highest predictive performance (R²-log: 0.854, Spearman: 0.933), closely followed by PURE-ML (R²-log: 0.789, Spearman: 0.896).
- CMT-PINN and PURE-ML achieved 65.9% and 61.0% prediction accuracy within twofold error, respectively.
- Models trained directly on concentration-time data outperformed those using derived PK parameters, especially with limited data.
Conclusions:
- Predicting PK behavior from molecular structures before synthesis is feasible.
- Computational approaches like CMT-PINN and PURE-ML enable informed compound selection early in drug discovery, reducing costs and timelines.
- These methods have the potential to reduce reliance on animal studies and accelerate pharmaceutical development.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Physiological Models
